Reproductive issues in inflammatory bowel disease.
Saha
Sumona
S
University of Wisconsin School of Medicine & Public Health, Madison, WI 53792, USA. ssaha@medicine.wisc.edu
Esposti
Silvia Degli
SD
D000223:Adaptation, Psychological; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007247:Infertility, Female / Q000453:epidemiology / Q000209:etiology*; D007248:Infertility, Male / Q000453:epidemiology / Q000209:etiology*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D019804:Mesalamine / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology* / Q000628:therapy; D043762:Reproductive Behavior; D013315:Stress, Psychological; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D019804:Mesalamine; D015122:Mercaptopurine; D001379:Azathioprine